# Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)

> **NCT05180526** · PHASE4 · UNKNOWN · sponsor: **Bio-Thera Solutions** · enrollment: 60 (actual)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** QLETLI

## Key facts

- **NCT ID:** NCT05180526
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-27
- **Primary completion:** 2024-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05180526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05180526, "Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05180526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*